Spotlight: Rising stars in cytology

It is my great pleasure to introduce to you Dr Vincenzo Fiorentino, a true rising star in the field of cytopathology. I have had the privilege of collaborating with Dr Fiorentino on numerous research projects and have witnessed firsthand his remarkable intellect, dedication, and profound commitment to the specialty of pathology and cytopathology. Dr Fiorentino's academic journey began at the Catholic University of Rome in Italy, where he earned his medical degree in 2015 and subsequently completed his specialization in anatomic pathology and cytopathology with honors in 2020. During his training at the Agostino Gemelli University Hospital of Rome, he distinguished himself as a keen and insightful trainee and laid a strong foundation for his future. He has since become a valued researcher in the Department of Human Pathology at the University of Messina, where he continues his impactful work. Dr Fiorentino has rapidly established himself as a prolific and influential academic. He has already coauthored an impressive portfolio of more than 70 peer-reviewed publications, with a significant number of these in high-impact journals. His research focuses on crucial and challenging areas within the field of pathology and cytopathology, including the molecular and cytological diagnosis of urological, thyroid, and head and neck diseases. Dr Fiorentino is an energetic and engaged member of the international pathology community and has been invited to major conferences, such as the European Congress of Pathology and the national Italian Society of Anatomic Pathology and Diagnostic Cytology/Italian Division of the International Academy of Pathology congress in Italy. His work has been recognized with prestigious honors, including an award at the Cytopathology World Wide contest during the 22nd International Congress of Cytology held in Florence, a testament to the quality and significance of his research. Furthermore, demonstrating the high reputation that he has achieved with his peers, he contributes his expertise as a peer reviewer for numerous international scientific journals and serves on the editorial boards of several journals. Dr Fiorentino embodies the ideal of a modern pathologist, as he seamlessly integrates classic morphology with advanced molecular techniques to push the boundaries of diagnostic accuracy and prognostic understanding. He is a brilliant collaborator, a valued colleague, and a clear leader in the next generation of pathologists. It has been a pleasure to watch his career flourish, and I am certain that he will continue to make significant and lasting contributions to cytopathology. —Guido Fadda, MD, MIAC My path to cytopathology was fundamentally shaped by a fascination with the diagnostic process at its most elemental level. While pathology in general offers the profound satisfaction of providing a definitive answer, I was drawn to the unique elegance and challenge of cytopathology. The ability to render a critical diagnosis from a minute collection of cells, often obtained through minimally invasive procedures, felt like the purest form of morphological detective work. This impression was solidified under the guidance of Professor Fadda, who demonstrated that cytopathology is not just a science but also an art, requiring a keen eye to interpret the subtle stories that cells tell. The direct and immediate impact this practice has on patient care, often serving as the very first step in their treatment journey, provides a powerful and constant sense of purpose that continues to inspire me. In the next five years, I envision cytopathology evolving into a far more integrated and powerful discipline, with its morphological foundations augmented by technology. I do not see the cytopathologist being replaced, but rather enhanced. Digital pathology and artificial intelligence will become indispensable tools, streamlining workflows and assisting in the detection of rare events, which will free up pathologists to focus on more complex cases and ancillary studies. Furthermore, the field will be central to the era of personalized medicine. Cytology samples, being minimally invasive, are perfect sources for the molecular and genomic testing that guides targeted therapies. The cytopathologist of the near future will be an integrative diagnostician, expertly combining cellular morphology with molecular data to provide clinicians with a comprehensive and actionable report, making our specialty more vital than ever. For any young investigator entering this field, my primary advice would be to cultivate an insatiable curiosity and to seek out dedicated mentorship. I cannot overstate the importance of learning from an experienced guide; my own development is inextricably linked to the wisdom and direction I have received from Professor Fadda. It is crucial to first build a rock-solid foundation in classical morphology, as this is the bedrock upon which all other skills are built. At the same time, one must embrace the technological and molecular advancements that are shaping our future. Do not be intimidated by digital pathology or next-generation sequencing, but rather strive to become the bridge between traditional expertise and innovative techniques. Finally, always maintain a close dialogue with clinical colleagues, because understanding the clinical question is essential to providing a truly meaningful pathological answer. As a young investigator, my most valuable resource is unquestionably human interaction and mentorship. The daily opportunity to discuss challenging cases and research ideas with my colleagues provides an educational depth that no book can replicate. Conferences are also vital not just for presenting work but for engaging in spontaneous conversations that often spark new ideas. Alongside this, I rely on a blend of print and online publications. Foundational textbooks remain on my desk as the essential source of core principles, while I turn to leading journals to stay at the cutting edge of research and evolving diagnostic criteria. For daily practice and quick reference, online resources like specialized pathology websites and comprehensive databases are indispensable for their accessibility and breadth of information. It is this dynamic interplay between mentorship, collaboration, and a curated selection of literature that supports my growth in the field. I find synergy between my research interests in genitourinary cytopathology, particularly urinary cytology, and thyroid cytology. I plan to build on my knowledge and experience in these areas and further our understanding and diagnostic ability, with a specific focus on integrating molecular findings with cytomorphology. My goal is to help to refine risk stratification and diagnostic accuracy, especially in diagnostically challenging cases such as indeterminate thyroid nodules. By exploring the role of molecular markers in these contexts, I hope that my research contributes to a more precise and personalized diagnostic framework in cytopathology.

Authors

Institutions

Publication Details

Journal
Cancer Cytopathology
Published
2025-09-13
DOI
https://doi.org/10.1002/cncy.70042
Primary Topic
Advances in Oncology and Radiotherapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spotlight: Rising stars in cytology

Vincenzo Fiorentino
Cancer Cytopathology
Advances in Oncology and Radiotherapy
article

Spotlight: Rising stars in cytology

Vincenzo Fiorentino
article en

Abstract

It is my great pleasure to introduce to you Dr Vincenzo Fiorentino, a true rising star in the field of cytopathology. I have had the privilege of collaborating with Dr Fiorentino on numerous research projects and have witnessed firsthand his remarkable intellect, dedication, and profound commitment to the specialty of pathology and cytopathology. Dr Fiorentino's academic journey began at the Catholic University of Rome in Italy, where he earned his medical degree in 2015 and subsequently completed his specialization in anatomic pathology and cytopathology with honors in 2020. During his training at the Agostino Gemelli University Hospital of Rome, he distinguished himself as a keen and insightful trainee and laid a strong foundation for his future. He has since become a valued researcher in the Department of Human Pathology at the University of Messina, where he continues his impactful work. Dr Fiorentino has rapidly established himself as a prolific and influential academic. He has already coauthored an impressive portfolio of more than 70 peer-reviewed publications, with a significant number of these in high-impact journals. His research focuses on crucial and challenging areas within the field of pathology and cytopathology, including the molecular and cytological diagnosis of urological, thyroid, and head and neck diseases. Dr Fiorentino is an energetic and engaged member of the international pathology community and has been invited to major conferences, such as the European Congress of Pathology and the national Italian Society of Anatomic Pathology and Diagnostic Cytology/Italian Division of the International Academy of Pathology congress in Italy. His work has been recognized with prestigious honors, including an award at the Cytopathology World Wide contest during the 22nd International Congress of Cytology held in Florence, a testament to the quality and significance of his research. Furthermore, demonstrating the high reputation that he has achieved with his peers, he contributes his expertise as a peer reviewer for numerous international scientific journals and serves on the editorial boards of several journals. Dr Fiorentino embodies the ideal of a modern pathologist, as he seamlessly integrates classic morphology with advanced molecular techniques to push the boundaries of diagnostic accuracy and prognostic understanding. He is a brilliant collaborator, a valued colleague, and a clear leader in the next generation of pathologists. It has been a pleasure to watch his career flourish, and I am certain that he will continue to make significant and lasting contributions to cytopathology. —Guido Fadda, MD, MIAC My path to cytopathology was fundamentally shaped by a fascination with the diagnostic process at its most elemental level. While pathology in general offers the profound satisfaction of providing a definitive answer, I was drawn to the unique elegance and challenge of cytopathology. The ability to render a critical diagnosis from a minute collection of cells, often obtained through minimally invasive procedures, felt like the purest form of morphological detective work. This impression was solidified under the guidance of Professor Fadda, who demonstrated that cytopathology is not just a science but also an art, requiring a keen eye to interpret the subtle stories that cells tell. The direct and immediate impact this practice has on patient care, often serving as the very first step in their treatment journey, provides a powerful and constant sense of purpose that continues to inspire me. In the next five years, I envision cytopathology evolving into a far more integrated and powerful discipline, with its morphological foundations augmented by technology. I do not see the cytopathologist being replaced, but rather enhanced. Digital pathology and artificial intelligence will become indispensable tools, streamlining workflows and assisting in the detection of rare events, which will free up pathologists to focus on more complex cases and ancillary studies. Furthermore, the field will be central to the era of personalized medicine. Cytology samples, being minimally invasive, are perfect sources for the molecular and genomic testing that guides targeted therapies. The cytopathologist of the near future will be an integrative diagnostician, expertly combining cellular morphology with molecular data to provide clinicians with a comprehensive and actionable report, making our specialty more vital than ever. For any young investigator entering this field, my primary advice would be to cultivate an insatiable curiosity and to seek out dedicated mentorship. I cannot overstate the importance of learning from an experienced guide; my own development is inextricably linked to the wisdom and direction I have received from Professor Fadda. It is crucial to first build a rock-solid foundation in classical morphology, as this is the bedrock upon which all other skills are built. At the same time, one must embrace the technological and molecular advancements that are shaping our future. Do not be intimidated by digital pathology or next-generation sequencing, but rather strive to become the bridge between traditional expertise and innovative techniques. Finally, always maintain a close dialogue with clinical colleagues, because understanding the clinical question is essential to providing a truly meaningful pathological answer. As a young investigator, my most valuable resource is unquestionably human interaction and mentorship. The daily opportunity to discuss challenging cases and research ideas with my colleagues provides an educational depth that no book can replicate. Conferences are also vital not just for presenting work but for engaging in spontaneous conversations that often spark new ideas. Alongside this, I rely on a blend of print and online publications. Foundational textbooks remain on my desk as the essential source of core principles, while I turn to leading journals to stay at the cutting edge of research and evolving diagnostic criteria. For daily practice and quick reference, online resources like specialized pathology websites and comprehensive databases are indispensable for their accessibility and breadth of information. It is this dynamic interplay between mentorship, collaboration, and a curated selection of literature that supports my growth in the field. I find synergy between my research interests in genitourinary cytopathology, particularly urinary cytology, and thyroid cytology. I plan to build on my knowledge and experience in these areas and further our understanding and diagnostic ability, with a specific focus on integrating molecular findings with cytomorphology. My goal is to help to refine risk stratification and diagnostic accuracy, especially in diagnostically challenging cases such as indeterminate thyroid nodules. By exploring the role of molecular markers in these contexts, I hope that my research contributes to a more precise and personalized diagnostic framework in cytopathology.

Cancer CytopathologyVol. 133(10)
University of Messina (IT)
Openalex Percentile: Top 66%
Advances in Oncology and Radiotherapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.